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Clinical pharmacy practiceAbstract The availability of suppositories in Hungary, especially in clinical pharmacy practice, is
usually provided by extemporaneous preparations. Due to the known advantages of rectal drug
administration, its beneﬁts are frequently utilized in pediatrics. However, errors during the extem-
poraneous manufacturing process can lead to non-homogenous drug distribution within the dosage
units. To determine the root cause of these errors and provide corrective actions, we studied sup-
pository samples prepared with exactly known errors using both cerimetric titration and HPLC
technique. Our results show that the most frequent technological error occurs when the pharmacist
fails to use the correct displacement factor in the calculations which could lead to a 4.6% increase/
decrease in the assay in individual dosage units. The second most important source of error can
occur when the molding excess is calculated solely for the suppository base. This can further dilute
the ﬁnal suppository drug concentration causing the assay to be as low as 80%. As a conclusion we
emphasize that the application of predetermined displacement factors in calculations for the formu-
Dosage uniformity problems which occur due to technological errors in extemporaneously 339lation of suppositories is highly important, which enables the pharmacist to produce a ﬁnal product
containing exactly the determined dose of an active substance despite the different densities of the
components.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Drugs used for rectal administration are frequently supplied by
independent pharmacies and especially clinical pharmacies.
This route of administration is very important in pediatrics.
Pharmaceuticals used for the treatment of fever, pain, spasms,
asthmatic symptoms and vomiting can be administrated rec-
tally (Abd-el-Maeboud et al., 1991; Dahl et al., 2000; Fumo-
leau et al., 1997; Kauss et al., 2012; Okabayashi et al., 2012;
Richter et al., 2012; Sabchareon et al., 1998; Shiohira et al.,
2009; Tinner et al., 2013). Approximately 80% of the suppos-
itories used in Central Europe are produced extemporaneously
using the molding technique. In clinical pharmacies quantities
of 100–300 and in independent pharmacies 10–12 suppositories
are generally molded as one batch. Suspension suppositories,
in particular, are formulated with a solid fatty vehicle (‘‘e.g.’’
Witepsol 35) or a combination of this suppository base with
surfactants (Rowe et al., 2003). The core of this technology
is the dispersion of the ﬁnely powdered drug with the molten
suppository base. After which, the suspension is molded under
continuous stirring. Fatty suppository bases have very low vis-
cosities, which decrease still further with an increase in temper-
ature, causing rapid sedimentation of the suspended particles
and leading to a non-homogeneous product. When the liquid
mass is molded at around the solidiﬁcation point, solidiﬁcation
occurs immediately as the mass enters the mold, making fur-
ther additions of the base and drug impossible. In the calcula-
tion of the suppository base weight, the following formula
must be applied (Eq. (1)):
Tm ¼ E
Xn
i¼1
fi  si ð1Þ
where Tm is the suppository base to be weighed, E is the cali-
bration constant of the mold, fi is the displacement factor of
the ith component and si is the weight of the ith component.
During the calculation of a correct formula, it is not sufﬁcient
to subtract the weight of the solid components from the ﬁnal
weight of the suppository to obtain the required amount of
the suppository base. We must also know the value of E for
the speciﬁc mold and speciﬁc suppository base, which can be
determined through independent measurements. Ten supposi-
tories are usually prepared with the mold, using the pure base,
and after cooling they are weighed and the average suppository
weight is calculated. This average value will be used as the cal-
ibration constant for the mold for any speciﬁc base. Since the
density of the active ingredient (hereinafter referred to as
‘‘API’’) incorporated into the suppository base can differ from
that of the base itself, the displacement factor (f) is required to
compensate for the difference in densities. The value of f,
which shows how much base will be displaced by a unit weight
of an API, can be calculated from the following equation (Eq.
(2)):
f ¼ 100  ðE GÞ
G  x þ 1 ð2Þwhere E is the weight of the blank suppository containing only
base, G is the weight of the suppository containing an API in a
known concentration, and x is the API content of the suppos-
itory in weight percentage.
If the pharmacist fails to carry out the steps in strict accor-
dance with these rules, signiﬁcant deviations will be observed
in the results for the homogeneity of the batch and in the total
drug content of the batch.In this research we report on an
investigation of samples prepared in pharmacies, with a special
emphasis on the homogeneity and the total API content of the
batches. The circumstances of the preparation of the supposi-
tories were known in all cases and are presented. In pharma-
cies, the f-values of the most frequent APIs in the most
common bases are not generally available. According to a
good manufacturing practice pharmacists apply the participle
of overage during the calculation of the batch composition,
but an incorrect calculation for the amount of vehicle required
and other technological errors may lead to serious deviations
in the ﬁnal dosage for the individual suppositories (Allen,
2007; Miseta and Soo´s-Csa´nyi, 2011; Ra´cz and Selmeczi,
1991).
2. Materials and methods
2.1. Materials
HPLC grade solvents and triple-distilled water were used dur-
ing the chromatographic measurements. For the preparation
of the HPLC mobile phases and sample preparation solvents,
the following materials were used: 4-dimethylaminoantipyrine
(Sigma–Aldrich, St. Louis, MO, USA), methanol (Chromasolv
for HPLC, Sigma–Aldrich, St. Louis, MO, USA), sodium ace-
tate (Reanal, Budapest, Hungary), acetic acid 96% (Molar
Chemicals, Budapest, Hungary), sodium hydroxide (Reanal,
Budapest, Hungary) and sodium chloride (VWR, Prolabo,
Leuven, Belgium). Volumetric solutions for the cerimetric
titrations were prepared with the following materials: ceriu-
m(IV) sulfate tetrahydrate (Panreac, Barcelona, Spain), sulfu-
ric acid 96% (Farmitalia Carlo Erba, Milano, Italy) and
ferroin-solution, 1/40 M (Reanal, Budapest, Hungary).
Commercially-made suppositories were used during the
comparisons for the analytical methods. The reference product
was Suppositorium antipyreticum pro parvulo FoNo VII.
Naturland (Naturland Magyarorsza´g Kft., Budapest, Hun-
gary), which contained 150 mg of aminophenazone per sup-
pository in a solid fatty suppository base. One box contains
six suppositories (Paa´l, 2003).
Samples were also prepared in regular pharmacies by the
molding technique, according to the following procedure.
Ten suppositories were obtained from 15 independent pharma-
cies with a labeled claim of 100 mg of aminophenazone in each
suppository. The choice of vehicle for the suppository was left
to the responsibility of the pharmacist at the site. Practically all
of the samples were prepared with a solid fatty base. In each
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made during the sample preparation.
2.2. Test methods
2.2.1. Cerimetric titration
The basis of the drug content determination is the use of a cer-
imetric redox titration method (Ro´zsa, 1953), During this as-
say the nascent oxygen evolved from the reaction of Ce(IV)
with water oxidizes aminophenazone. The end-point of the
titration is observed by the change in color of ferroin added
as the indicator. During the sample preparation, whether from
the commercially prepared suppository or the extemporane-
ously prepared ones, one suppository is melted over a 40 C
water bath and 3 replicate samples of 0.20–0.30 g are weighed
from the molten mass into titration ﬂasks. A 10.0 ml portion of
15% sulfuric acid is added to each sample and the mixture is
heated to 40 C to extract the API from the suppository base.
The mixture is then cooled to room temperature. A 15 ml por-
tion of distilled water is added, and after mixing, one drop of
ferroin as indicator is added. This is then titrated with 0.05 M
cerium(IV) sulfate volumetric solution until the color of the
solution changes from orange to green and remains green for
at least 1 min (Paulenova et al., 2002; Townshend, 2005).
2.2.2. Assay of aminophenazone by HPLC
HPLC measurements were carried out on a Shimadzu Promi-
nence UHPLC system (Shimadzu Corp., Kyoto, Japan)
equipped with an LC-20AD pump, a four port solenoid mixing
valve, a CTO-20A column oven, a DGU-20ASR degasser, and
an SPD-M20A UV/VIS PDA detector with a 10 mm optical
path length ﬂow cell. Sample injection was performed with a
Rheodyne six port manual injector valve ﬁtted with a 20 ll
sample loop. Separation was achieved on a Hypersil ODS
(C18) 150 · 4.6 mm, 5 lm column (Thermo Scientiﬁc, Key-
stone, UK). Data acquisition and peak integration were car-
ried out with the LC Solution (Shimadzu Corp., Kyoto,
Japan) chromatographic data acquisition and processing
software.
The mobile phase was methanol:sodium acetate (pH 5.5;
0.05 M) (60:40, v/v). The pH of the sodium acetate buffer solu-
tion was adjusted to the desired value with acetic acid. The
ﬂow rate of the reversed-phase isocratic eluent was 1.5 ml/
min and the run time was 5 min. The chromatographic column
was thermostated at 30 C throughout the separation. The
chromatograms were recorded at 243 nm. The retention timeTable 1 Assay results for factory-produced suppository samples, m
Sample Cerimetric titration
Replicates%
S1 101.6 107.2 103.5
S2 98.9 99.3 97.5
S3 106.3 100.7 100.3
S4 96.1 100.7 97.1
S5 100.9 110.4 102.1
S6 103.6 104.0 104.7
Average
SDof aminophenazone was found to be 1.8 min. The applied
method was validated. The samples were prepared with a tech-
nique elaborated previously by our research group. The exactly
weighed suppository was melted over a 40 C water bath in a
50:50 (v/v) methanol:water mixture. After identiﬁcation of
the suppository base on the basis of its physicochemical prop-
erties, the base was separated from the solution if necessary.
The sample solution was then ﬁltered through a 0.45 lm pore
size nylon membrane ﬁlter. The solution was injected onto the
HPLC through the Rheodyne injector valve.
3. Results and discussion
3.1. Comparison of the cerimetric titration and the HPLC
method
We compared the two analytical methods by measuring two
sets of six commercially-made suppositories from the same
batch having the exact lot number. The individual assays for
the suppositories were carried out by either the volumetric or
the chromatographic technique. All of the ﬁnal results (the
averages of the three replicates for each of the six suppositories
in the case of the titrimetric method, and the individual sup-
pository assay value in the case of the chromatographic deter-
mination) fell within the range 95–105%, which conforms to
the strictest requirements of the European Pharmacopoeia.
The individual content data are presented in Table 1.
It should be noted that the volumetric results exhibit a lar-
ger standard deviation than that of the chromatographic re-
sults, but the preparation of samples for titration (one total
of 18 replicate samples prepared from the molten suppository)
involves a higher level of uncertainty, and this can therefore be
considered acceptable. A comparison of the two methods re-
veals that both can be used for the analysis of suppositories
containing aminophenazone.
3.2. Dosage uniformity study of extemporaneously prepared
suppositories
We additionally studied pediatric suppositories with the
composition described in Section 2.1. All samples were from
different Hungarian independent pharmacies, and each sample
consisted of 10 individual suppositories. The manufacturing
technology for each of the samples was known to us with the
pharmacists committing intentional technological errors
during the preparation of the suppositories. The extemporane-easured by cerimetric titration or the HPLC method.
Sample HPLC
Average cont.% Content%
104.1 S7 103.9
98.5 S8 104.9
102.4 S9 102.8
98.0 S10 102.3
104.5 S11 103.9
104.1 S12 104.6
101.9 103.7
2.93 1.01
Figure 1 Mean API content for the samples, with the standard
deviations. An API content in the interval 85–115% is satisfac-
tory. Samples Ph1–Ph9: HPLC results; Samples Ph10–Ph15:
cerimetric titration results.
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pharmacies Ph1–Ph9 were measured with the HPLC technique
described in Section 2.2.2. The extemporaneously prepared
samples (containing 10 suppositories) from pharmacies
Ph10–Ph15 were tested for dosage uniformity with the titrimet-
ric method presented in Section 2.2.1. All of the ﬁndings (see
Fig. 1) were compared on the basis of the results given in
Section 3.1. It can be stated that two samples conformed to
the speciﬁcations of Ph. Eur. 7.8, ‘‘i.e.’’ the individual assay
values fell within the range 85–115% at level 1, and one further
sample would probably have conformed to the level 2 speciﬁ-
cation of 75–125% (Ph Eur 7.8). For the remaining samples,
generally either lower individual assay results or (in 2 samples)
signiﬁcant non-homogeneity was found, which are justiﬁed by
standard deviation values visible in Table 2.
3.3. Effects of f-value on the assay results
The possible consequences of the most common errors can be
illustrated utilizing a theoretical example. If the pharmacist
produced suppositories on the basis of the following parame-
ters: E= 1.7 g; f= 0.78 and s= 0.1 g then, according to
Eq. (1), Tm = 15.22 g for the 10 suppositories. If f-value is
not applied, but only the weight of the API is subtracted from
the value of E, then we have Tm = 16.0, which will result in an
assay which is 4.6% lower than the required value. If this error
is superimposed with the one when the calculated molding ex-
cess is taken solely from the suppository base (taking the re-
quired base for 12 dosage units instead of 10) then the
concentration of one suppository is diluted even further, to
80.3% of the intended theoretical value.Table 2 Average assay results on the samples and standard deviat
pharmacy.
Sample Ph1 Ph2 Ph3 Ph4 Ph5 Ph6 Ph7
Average% 87.7 56.1 75.6 74.8 85.8 84.7 86.9
SD 4.8 3.6 3.6 11.1 52.8 11.6 3.03.4. Effects of stirring on the homogeneity and total assay of the
samples
The suppository mass can be well homogenized by choosing an
appropriate rate of manual stirring or machine-based mixing.
Stirring during the molding process can help avoid the sedi-
mentation of the API in the container. Too slow a stirring rate
is not effective, however too fast a stirring rate may also lead
to errors: since air bubbles may be formed in the mass, which
will decrease the weight of the suppositories. Foam can be
formed from the surfactant-containing bases, or shearing
forces may appear, which decrease the viscosity of the suppos-
itory mass by rheodestruction, causing the rapid sedimentation
of the API. The ideal machine stirring speed for fat-based sup-
positories is recommended as 150 rpm.
The results demonstrate that the stirring technique for
extemporaneously prepared pharmacist suppositories before
and during the molding procedure was appropriate, with the
exception of a small number of serious cases. Those samples
can be considered homogeneous which gave SD 6 10 with re-
spect to the individual suppository assays. A larger deviation
can originate from the lack of stirring during molding, as
may be seen for samples 5, 7 and 16. Extremely large devia-
tions result when both thorough homogenization and stirring
during the molding process are omitted, which maybe ob-
served for samples 6 and 13. If (f) is not applied and the sup-
pository base is used in an excess amount, the assays for the
samples will fall below the lower limit of acceptance. If the
molten mass is not stirred during molding process, the decrease
in the API content becomes more serious since the suspended
material is sedimented, and the mold will contain an API –
which is depleted from the mixture.
4. Conclusions
The results for pediatric suppositories produced extemporane-
ously under predeﬁned conditions in Hungarian independent
pharmacies revealed that serious errors may arise if the rules
used in the pharmaceutical technology for preparing such sup-
positories are not strictly adhered to, and the assay results on
the individual dosage units may be affected. On the other
hand, suppositories prepared with strict adherence to the cor-
rect manufacturing practices conform to the speciﬁcations de-
scribed in Ph. Eur. 7.8. Since extemporaneously prepared
suppository preparations are frequently compounded and sup-
plied in central European clinical pharmaceutical practice be-
cause of the low costs involved, we would encourage the use
of and the inclusion of the f-values for the most common APIs
and for the most common suppository bases into the European
or national pharmacopoeias. To our knowledge the paucity of
this information prohibits the preparation of the ‘‘right’’ dose
for the ‘‘right’’ patient and may even do harm. Calibration ofions in the homogeneity study. Ph in the sample raw stands for
Ph8 Ph9 Ph10 Ph11 Ph12 Ph13 Ph14 Ph15
76.2 49.5 93.7 75.5 70.4 82.9 54.9 78.6
7.8 7.0 10.2 8.0 7.4 79.7 5.5 14.3
342 E´. Kalma´r et al.the mold and the determination of the f-value for these basic
common suppository bases can be accomplished very simply.Acknowledgements
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